Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
This was the first real step in a long regulatory process not the finish line
Protocol for a randomized phase II/III double-blind placebo-controlled trial to evaluate the safety and efficacy of extended-release metformin in amnestic mild cognitive impairment: metformin in Alzheimer dementia prevention (MAP)
*Correspondence: Jinhua Li, [email protected] Zhang, [email protected] These authors have contributed equally to this work ORCID: Jinhua Li, orcid.org/0000-0003-0085-9168 Xu Wang, orcid.org/0009-0007-7157-7156 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Eric: Gotcha
The nausea is temporary
US$ 21.64
US$ 21.52
US$ 25.73
US$ 28.96
US$ 24.45
US$ 24.51
US$ 21.99
US$ 22.12
US$ 23.84
